# Nuclear mechanobiology in confined cell migration

**Authors:** Hailee Patel, Simran Kaur, Richard B. Dickinson, Tanmay P. Lele

PMC · DOI: 10.1080/19491034.2026.2620879 · Nucleus · 2026-01-29

## TL;DR

This paper reviews how the cell nucleus responds to mechanical forces during migration through tight spaces in tissues.

## Contribution

The paper highlights the nucleus as a mechanoresponsive organelle that influences cell behavior during confined migration.

## Key findings

- The nucleus is not just a barrier but actively responds to mechanical forces during migration.
- Cytoskeletal forces and sub-nuclear structures play roles in nuclear deformation during migration.
- Understanding nuclear mechanobiology is key to explaining cell navigation in complex tissues.

## Abstract

Nuclear deformation is a central challenge for migration of cells through confined spaces in the tissue interstitium. In this paper, we review studies on the mechanical roles of the nucleus in confined cell migration. We focus on mechanical force generation by the cytoskeleton on the nuclear surface, the properties of sub-nuclear structures in the process, and functional responses of the nucleus in response to mechanical forces, all in the context of confined cell migration. An emerging theme is that the nucleus acts not only as a barrier for confined migration, but also as a mechanoresponsive organelle whose deformation feeds back to modify cell behaviors. Deciphering these complex processes will be key to understanding how cells navigate complex tissues in development, immunity, and cancer.

## Full-text entities

- **Genes:** ITGA9 (integrin subunit alpha 9) [NCBI Gene 3680] {aka ALPHA-RLC, ITGA4L, RLC}, SYNE2 (spectrin repeat containing nuclear envelope protein 2) [NCBI Gene 23224] {aka EDMD5, KASH2, NUA, NUANCE, Nesp2, Nesprin-2}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, BANF1 (barrier to autointegration nuclear assembly factor 1) [NCBI Gene 8815] {aka BAF, BCRP1, D14S1460, NGPS}, RBBP5 (RB binding protein 5, histone lysine methyltransferase complex subunit) [NCBI Gene 5929] {aka RBQ3, SWD1}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, VIM (vimentin) [NCBI Gene 7431], SYNE1 (spectrin repeat containing nuclear envelope protein 1) [NCBI Gene 23345] {aka 8B, AMC3, AMCM, ARCA1, C6orf98, CPG2}, PRDM9 (PR/SET domain 9) [NCBI Gene 56979] {aka KMT8B, MEISETZ, MSBP3, PFM6, ZNF899}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ECT2 (epithelial cell transforming 2) [NCBI Gene 1894] {aka ARHGEF31}, WDR5 (WD repeat domain 5) [NCBI Gene 11091] {aka BIG-3, BIG3, CFAP89, SWD3}, BRSK1 (BR serine/threonine kinase 1) [NCBI Gene 84446] {aka SAD-B, hSAD1}, TREX1 (three prime repair exonuclease 1) [NCBI Gene 11277] {aka AGS1, CRV, DRN3, HERNS, RVCLS}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CADM3 (cell adhesion molecule 3) [NCBI Gene 57863] {aka BIgR, CMT2FF, IGSF4B, NECL1, Necl-1, TSLL1}, PLA2G4A (phospholipase A2 group IVA) [NCBI Gene 5321] {aka GURDP, PLA2G4, cPLA2, cPLA2-alpha}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, CBX5 (chromobox 5) [NCBI Gene 23468] {aka HEL25, HP1, HP1A, HP1alpha}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, CLASP2 (cytoplasmic linker associated protein 2) [NCBI Gene 23122], MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}
- **Diseases:** Hutchinson-Gilford progeria syndrome (MESH:D011371), cervical cancer (MESH:D002583), metastasis (MESH:D009362), breast adenocarcinoma (MESH:D001943), glioblastoma (MESH:D005909), fibrosarcoma (MESH:D005354), lung carcinoma (MESH:D008175), ovarian cancer (MESH:D010051), Cancer (MESH:D009369)
- **Chemicals:** 3-Deazaneplanocin A (MESH:C048460), TSA (MESH:C012589), lipid membrane (MESH:D008563), arachidonic acid (MESH:D016718), calcium (MESH:D002118)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Homo sapiens (human, species) [taxon 9606], C. elegans [taxon 328850]
- **Cell lines:** IMR90 — Homo sapiens (Human), Finite cell line (CVCL_0347), CCRF-CEM — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0207), BT-549 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_1092), MEFs — Mus musculus (Mouse), Finite cell line (CVCL_9115), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), HO-8910 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_6868), HT-1080 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_0317), U251 — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0021), RPE1 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388), L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58), HeLa — Homo sapiens (Human), Human papillomavirus-related cervical squamous cell carcinoma, Cancer cell line (CVCL_T292), HEY — Homo sapiens (Human), High grade ovarian serous adenocarcinoma, Cancer cell line (CVCL_0297), HOS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0312), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), MDA-468 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0419), A375 melanoma — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0132), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), HL-60 — Homo sapiens (Human), Adult acute myeloid leukemia with maturation, Cancer cell line (CVCL_0002)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12867410/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12867410/full.md

## References

136 references — full list in the complete paper: https://tomesphere.com/paper/PMC12867410/full.md

---
Source: https://tomesphere.com/paper/PMC12867410